CENI, ELISABETTA
CENI, ELISABETTA
Scienze Biomediche, Sperimentali e Cliniche 'Mario Serio'
2D-DIGE proteomic analysis identifies new potential therapeutic targets for adrenocortical carcinoma
2015 Poli, Giada; Ceni, Elisabetta; Armignacco, Roberta; Ercolino, Tonino; Canu, Letizia; Baroni, Gianna; Nesi, Gabriella; Galli, Andrea; Mannelli, Massimo; Luconi, Michaela
8-Oxo-7,8-dihydro-2'-deoxyguanosine and other lesions along the coding strand of the exon 5 of the tumour suppressor gene P53 in a breast cancer case-control study.
2016 Brancato, B; Munnia, A; Cellai, F; Ceni, Elisabetta; Mello, Tommaso; Bianchi, Simonetta; Catarzi, S; Risso, Gg; Galli, Andrea; Peluso, Me
A MITOCHONDRIAL ROLE FOR THE CANCER-RELATED AAA plus ATP-ASE RUVBL1
2019 Mello, T; Simeone, I ; Materozzi, M ; Ceni, E; Polvani, S ; Tarocchi, M ; Galli, A
A mitochondrial role of RuvBL1 ATPase in the regulation of HCC cell metabolism
2021 Simeone, I; Guida, A; Materozzi, M; Polvani, S; Bani, D; Parri, M; Ceni, E; Galli, A; Mello, T
A N-TRUNCATED ISOFORM OF THE ORPHAN NUCLEAR RECEPTOR COUP-TFII MODULATES PANCREATIC CANCER PROGRESSION
2015 Polvani, S ; Tempesti, S; Tarocchi, M ; Marroncini, G ; Ceni, E ; Mello, T ; Farsi, M; Milani, S .
A new mechanism involving ERK contributes to rosiglitazone inhibition of tumor necrosis factor-alpha and interferon-gamma inflammatory effects in human endothelial cells
2008 A. Lombardi; G. Cantini; E. Piscitelli; S. Gelmini; M. Francalanci; T. Mello; E. Ceni; G. Varano; G. Forti; M. Rotondi; A. Galli; M. Serio; M. Luconi
A new regulator of mitochondrial OXPHOS in hepatocytes and HCC cell lines: the AAA plus ATPase RuvBL1
2019 I. Simeone , M. Materozzi , E. Ceni , S. Polvani , M. Tarocchi , A. Galli , T. Mello
Acetaldehyde induced collagen synthesis by inhibition of PPARgamma trascriptional activity via hydrogen peroxide-mediated activation of c-Abl non-receptor tyrosine kinase in human hepatic stellate cells
2005 A. Galli;E. Ceni;D. W. Crabb;M. Foschi;T. Mello;M. Tarocchi;C. Surrenti;S. Milani
Acetaldehyde induces c-fos and c-jun proto-oncogenes in fat-storing cell cultures through protein kinase C activation
1994 A.CASINI; G.GALLI; R.SALZANO; E.CENI; F.FRANCESCHELLI; C.M.ROTELLA; C.SURRENTI
Acetaldehyde inhibits peroxisome proliferator-activated receptor gamma (PPARg) transcriptional activity in hepatic stellate cells. A MAPk/pkcdelta-dependent mechanism.
2002 A. Galli;E. Ceni;D. W. Crabb;T. Mello;R. Salzano;C. Surrenti;M. Foschi;A. Casini
Acetaldehyde inhibits PPARgamma via H2O2-mediated c-Abl activation in human hepatic stellate cells.
2006 CENI E; CRABB DW; FOSCHI M; MELLO T; TAROCCHI M; PATUSSI V; MORALDI L; MORETTI R; MILANI S; C. SURRENTI; GALLI A
Acetaldehyde regulates the gene expression of matrix-metalloproteinase-1 and -2 in human fat-storing cells
1994 A.CASINI; E.CENI; R.SALZANO; G.GALLI; S.MILANI; D.SCHUPPAN; C.SURRENTI
Acycloguanosyl 5'-thymidyltriphosphate, a Thymidine Analogue Prodrug Activated by Telomerase, Reduces Pancreatic Tumor Growth in Mice.
2011 S.Polvani; M.Calamante; V.Foresta; E.Ceni; A.Mordini; A.Quattrone; M.D'Amico; C.Luchinat; I.Bertini; A.Galli
Alcohol induced hepatic fibrosis: role of acetaldehyde.
2008 Tommaso Mello; Elisabetta Ceni; Calogero Surrenti; Andrea Galli
Aldehyde Dehydrogenase-2 (aldh2) Gene Is Differently Expressed In Human Liver Fat-storing Cells (hfsc) and Liver-tissues
1993 A. CASINI;E. CENI;R. SALZANO;D. W. CRABB;C. SURRENTI
ANTAGONISTIC SIGNALLING BY PPARGAMMA AND ROSIGLITAZONE CONVERGE ON RUVBL1 REGULATION IN HCC CELLS
2014 Mello, T; Tarocchi, M; Perini, F; Buccoliero, F; Marroncini, G; Ceni, E; Polvani, S; Tempesti, S; Milani, S; Galli, A
Antidiabetic thiazolidinediones induce ductal differentiation but not apoptosis in pancreatic cancer cells.
2005 CENI E; MELLO T; TAROCCHI M; CRABB DW; CALDINI A; INVERNIZZI P; SURRENTI C; S. MILANI; GALLI A.
Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro
2002 A.GALLI; D.W.CRABB; E.CENI; R.SALZANO; T.MELLO; G.SVEGLIATI BARONI; F.RIDOLFI; L.TROZZI; C.SURRENTI; A.CASINI
Antidiabetic thiazolidinediones inhibit hepatic tumor formation in HBV transgenic mouse model.
2003 E. Ceni;D. W. Crabb;T. Mello;E. Villa;F. Schepis;M. Tarocchi;M. R. Biagini;C. Corrado;A. Casini;S. Milani;C. Surrenti; A. Galli
Antidiabetic thiazolidinediones inhibit invasiveness of pancreatic cancer cells via PPARgamma independent mechanisms
2004 GALLI A.; CENI E.; CRABB D.W.; MELLO T.; SALZANO R.; GRAPPONE C.; MILANI S.; SURRENTI E.; SURRENTI C.; CASINI A.